Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11909/j.issn.1671-5411.2017.01.006 http://scihub22266oqcxt.onion/10.11909/j.issn.1671-5411.2017.01.006 C5329735!5329735!28270844     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28270844&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Geriatr+Cardiol 2017 ; 14 (1): 67-72 Nephropedia Template TP {{tp|p=28270844|t=2017. New generations of dihydropyridines for treatment of hypertension |pdf=|usr=}}{{28270844}} gab.com Text New generations of dihydropyridines for treatment of hypertension JO: J Geriatr Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28270844 #FOAvip Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure. Twit Text FOAVip New generations of dihydropyridines for treatment of hypertension ????J Geriatr Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=28270844 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28270844 #FOAvip English Wikipedia <ref>{{Cite pmid|28270844}}</ref> New generations of dihydropyridines for treatment of hypertension #MMPMID28270844 Wang AL; Iadecola C; Wang G J Geriatr Cardiol 2017[Jan]; 14 (1): 67-72 PMID28270844show ga Since the calcium channel blocker (CCB) has become one of the most prescribed agents for antihypertensive monotherapy in the world, this brief review will focus on the recent research and development of the dihydropyridine (DHP) CCB, addressing pharmacological mechanisms for the clinical efficacy of the third and fourth generations of the DHP CCBs, especially on their possible central mechanisms underlying lowering blood pressure. äNew generations of dihydropyridines for treatment of hypertension (epmc).pdf DeepDyve Pubget Overpricing